The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »
The News: China’s Innovent Biologics Inc. has raised $150 million in a Series E crossover round, with Capital Group Private Markets picking up $90 million of the mega-round, according to Endpoints. The… Read more »
The News: Apitope International NV has taken a step closer to developing the first new treatment option in decades for thyroid disorder Graves’ disease after posting positive results in a… Read more »
The News: Rising healthcare stocks and fading qualms over an escalating Syrian conflict had Wall St. optimistic to start the week. Stocks had ended lower on Friday (April 13, 2018)… Read more »
1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »
The News: Cancer survivors may be able to manage the extreme fatigue they experience after treatment by knowingly taking a placebo pill, according to researchers at University of Alabama at… Read more »
The News: Four women had an extremely rare, aggressive and fatal type of ovarian cancer. There was no standard treatment. All four women, who lived in different countries, asked their… Read more »
Steve’s Take: Cutting-edge biotech startups and more established privately-funded but publicly held hopefuls are far and away the winners of the race for deep-pocket investors since New Year’s. I thought… Read more »
The News: Warren Buffett says his joint venture with Jeff Bezos and Jamie Dimon is going for something bigger than shaving a few percentage points off healthcare costs. The big… Read more »
The News: Celltrion Inc. said on February 14, 2018 that it has received approval to sell its replica version of Roche Holding AG’s (Basel CHE) breast-cancer blockbuster Herceptin in Europe…. Read more »
